IL1B and Alzheimer disease: The binding of these six components to inflammatory mediators (IL-6, TNF-α, IL-1β) and Alzheimer’s disease-related protein targets was studied by molecular docking technology, and it was found that these six components all have low binding energy and good binding fraction.